Expensive medical technologies and "indication extrapolation": the case of implantable cardioverter-defibrillators

Am Heart J. 2000 Sep;140(3):419-22. doi: 10.1067/mhj.2000.108516.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cost-Benefit Analysis
  • Decision Making
  • Defibrillators, Implantable / economics*
  • Female
  • Health Care Costs*
  • Humans
  • Male
  • Medical Laboratory Science / economics
  • Middle Aged
  • Myocardial Infarction
  • Ventricular Fibrillation / therapy*